View Cart
My AccountInfectious Disease Diagnostic Solutions
Microbix Phone+1803294983432Microbix Emailcustomer.service@microbix.com
Microbix Logo
Request Catalogue Contact Us
  • Services
    • Assay Development Solutions
    • Custom Vial Filling Services
  • Products
    • Reference Materials (QUANTDxâ„¢)
    • Antigens
      • All Antigens
      • Childhood Disease Antigens
      • Dengue Antigens
      • STI Antigens
      • ToRCH Antigens
      • Respiratory Antigens
      • Other Antigens
    • External Quality Controls (QAPsâ„¢)
      • All External QC Products
      • Respiratory Viral Panel
      • STI Panel
      • HPV Panel
      • Gastrointestinal Panel
      • Genital Ulcer Panel
      • Vaginal Infections Panel
      • ONBOARDx Kits
      • Proficiency Testing Panel
      • Technical Resources
    • DxTMâ„¢ Viral Transport Medium
    • Control Elution Buffer
    • Kinlytic (Urokinase)
  • About
    • Who We Are
    • Who We Work With
    • Quality
    • Board of Directors
    • Our Senior Team
    • Careers
  • Resources
    • Catalogues & Brochures
    • White Papers
    • Poster Publication
    • Podcasts
  • Investors
    • News Releases
    • Financial Reports
    • Corporate Presentations
    • Analyst Coverage
    • Corporate Governance
    • Stock Information
Contact Us
Microbix Updates Investor Presentation on its Website

Microbix Updates Investor Presentation on its Website

by Shitika Kulshreshtha | Jan 9, 2026 | News Releases

In Response to OSC Requirements to Explain EBITDA (a non-IFRS measure)   MISSISSAUGA, CANADA, January 9, 2026 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it has...
Microbix Commercializes SARS-CoV-2 (COVID) Recombinant Antigen

Microbix Commercializes SARS-CoV-2 (COVID) Recombinant Antigen

by Shitika Kulshreshtha | Jan 7, 2026 | News Releases

For Usage in QAPs and Test Manufacturing   MISSISSAUGA, CANADA, January 7, 2026 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces the commercial usage of its first recombinant antigen...
Microbix Reports Results for Q4 and Fiscal 2025

Microbix Reports Results for Q4 and Fiscal 2025

by Shitika Kulshreshtha | Dec 18, 2025 | News Releases

Full-Year Revenues of $18.6 million and Net Loss of $2.2 million   MISSISSAUGA, CANADA, December 18, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its fiscal...

Microbix Schedules Release of Results for Q4 Fiscal 2025

by Shitika Kulshreshtha | Dec 11, 2025 | News Releases

Results Release and Webinar Discussion on Morning of December 18, 2025   MISSISSAUGA, CANADA, December 11, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it expects...
Microbix Launches New Products to Support H3N2 Flu Testing

Microbix Launches New Products to Support H3N2 Flu Testing

by Shitika Kulshreshtha | Dec 10, 2025 | News Releases

Test-Controls & Reference Materials for Labs & Test-Makers   MISSISSAUGA, CANADA, December 10, 2025 – Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces the commercial launch of...
« Older Entries
  • Investors
  • Legal
  • Contact
  • News Releases
  • Accessibility
  • Careers
Microbix Funded By
Lab Image Lab Image

Get the Latest from Microbix—Straight to Your Inbox!

Stay up to date with news releases, product updates, tradeshows and conference information, and newsletters.


    Maybe later, science waits for no one